S100B and melanoma: There is increasing evidence that time-dependent evaluation of serial blood measurements of S100B is useful in order to follow melanoma patients (Figure 2); many reports have shown that S100B levels are correlated with clinical stage (the higher the level, the more advanced the stage) and could be used to monitor the effectiveness of antitumoral treatment whatever the type of the treatment (surgical, chemotherapy, immunotherapy).